<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711422728</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711422728</article-id>
<title-group>
<article-title>Ameliorative effect of vitamin C on hexavalent chromium-induced delay in sexual maturation and oxidative stress in developing Wistar rat ovary and uterus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Samuel</surname>
<given-names>Jawahar B</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711422728">1</xref>
<xref ref-type="corresp" rid="corresp1-0748233711422728"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanley</surname>
<given-names>Jone A</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422728">2</xref>
<xref ref-type="aff" rid="aff3-0748233711422728">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vengatesh</surname>
<given-names>Ganapathy</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422728">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Princess</surname>
<given-names>Rajendran A</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711422728">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muthusami</surname>
<given-names>Sridhar</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422728">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roopha</surname>
<given-names>Dailiah P</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711422728">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suthagar</surname>
<given-names>Esakky</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422728">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Kathiresh M</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422728">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sebastian</surname>
<given-names>Maria S</given-names>
</name>
<xref ref-type="aff" rid="aff4-0748233711422728">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aruldhas</surname>
<given-names>Michael M</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422728">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0748233711422728"><label>1</label>Department of Zoology, St. John’s College, Thirunelveli, Tamil Nadu, India</aff>
<aff id="aff2-0748233711422728"><label>2</label>Department of Endocrinology, Dr ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, Tamil Nadu, India</aff>
<aff id="aff3-0748233711422728"><label>3</label>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA</aff>
<aff id="aff4-0748233711422728"><label>4</label>Department of Zoology, St. Xavier’s College, Thirunelveli, Tamil Nadu, India</aff>
<author-notes>
<corresp id="corresp1-0748233711422728">Jawahar B Samuel, Department of Zoology, St. John’s College, Thirunelveli, Tamil Nadu 627002, India Email: <email>drbjsamuel@yahoo.co.in</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>28</volume>
<issue>8</issue>
<fpage>720</fpage>
<lpage>733</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Hexavalent chromium (CrVI) is a highly toxic metal and major environmental pollutant and is extensively used in more than 50 industries. The major route of CrVI exposure for the general population is oral intake. Chromium is considered an important nutrient responsible for carbohydrate metabolism. However, excess CrVI exposure is associated with various pathological conditions including reproductive dysfunction. CrVI can traverse the placental barrier and cause wide range of abnormalities in fetal development. Cr is transported to offspring through mother’s milk in lactating women exposed to CrVI. Therefore, the present study was carried out to determine the toxic effects of lactational CrVI exposure on ovary and uterus and the beneficial role of vitamin C in preventing/ameliorating the toxic effects of CrVI in developing female Wistar rats. Generation of oxidative stress is considered one of the plausible mechanisms behind Cr-induced cellular deteriorations. The present study evidenced a decrease in the specific activities of antioxidants, serum testosterone and progesterone and an increase in the levels of H<sub>2</sub>O<sub>2</sub>, lipid peroxidation (LPO) and follicle stimulating hormone in rats exposed to CrVI when compared to control. CrVI exposure also delayed the sexual maturation and extended the estrous cycle. Simultaneous administration of vitamin C significantly prevented the increase in LPO and enhanced the antioxidant status. These results suggest the protective effect of vitamin C against the CrVI exposure-induced toxicity and attest the significance of antioxidants in diet.</p>
</abstract>
<kwd-group>
<kwd>Chromium</kwd>
<kwd>ovary</kwd>
<kwd>uterus</kwd>
<kwd>oxidative stress</kwd>
<kwd>sexual maturation</kwd>
<kwd>vitamin C</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>In recent years, contamination of the environment by chromium (Cr) has become a major area of concern. Cr exists in multiple oxidation states. The hexavalent chromium (CrVI) and trivalent chromium (CrIII) states are most important from a biological and an industrial standpoint. CrIII is an important nutrient for the human body; it enhances the action of insulin by increasing the number of insulin receptors, and enhances insulin binding and insulin sensitivity (<xref ref-type="bibr" rid="bibr2-0748233711422728">Anderson, 2000</xref>). CrVI is an industrial contaminant of landfills and waterways (<xref ref-type="bibr" rid="bibr13-0748233711422728">Cohen et al., 1993</xref>) and used on a large scale in more than 50 industries including metallurgical, electroplating, production of paints and pigments, tanning, wood preservation, pulp and paper production (<xref ref-type="bibr" rid="bibr10-0748233711422728">Barceloux, 1999</xref>). The tanning industry is the large contributor of Cr pollution in water resources. In India about 2000–3200 tones of elemental Cr escape into the environment annually from the tanning industries, with a Cr concentration ranging between 2000 and 5000 mg L<sup>−1</sup> in the effluent compared to the recommended permissible limit of 2 mg L<sup>−1</sup> (<xref ref-type="bibr" rid="bibr12-0748233711422728">Chandra et al., 1997</xref>). Sukinda (Orissa), Vapi (Gujarat) and Ranipet (Tamil Nadu) in India were listed as the world’s top 10 worst polluted places because their drinking water is heavily contaminated with CrVI (The Blacksmith Institute, <xref ref-type="bibr" rid="bibr56-0748233711422728">2007</xref>). Excessive levels of Cr have been shown to produce various health hazards including reproductive dysfunction (<xref ref-type="bibr" rid="bibr1-0748233711422728">Al-Hamood et al., 1998</xref>). The other health hazards caused by Cr include dermatitis bronchitis, lung cancer and nasal ulceration (<xref ref-type="bibr" rid="bibr11-0748233711422728">Burrows, 1978</xref>; <xref ref-type="bibr" rid="bibr21-0748233711422728">Halasova et al., 2009</xref>).</p>
<p>Occupational exposure to Cr is found among approximately half a million industrial workers in the United States and several millions worldwide; significant contamination with CrVI has been found in approximately 30% of the drinking water sources in California (<xref ref-type="bibr" rid="bibr43-0748233711422728">Salnikow and Zhitkovich, 2008</xref>). The deposition of CrVI wastes in landfills and waterways by chromate industries affects millions of people who reside in the vicinity of dangerously polluted sites. Women working in dichromate manufacturing industries and living around Cr-contaminated areas encounter gynecological illness, postnatal hemorrhage and birth complications with high levels of Cr in blood and urine (<xref ref-type="bibr" rid="bibr19-0748233711422728">Greene et al., 2010</xref>; <xref ref-type="bibr" rid="bibr25-0748233711422728">Jendryczko et al., 1984</xref>; <xref ref-type="bibr" rid="bibr49-0748233711422728">Shmitova, 1980</xref>; <xref ref-type="bibr" rid="bibr59-0748233711422728">Zhang et al., 1992</xref>).</p>
<p>It is known that environmental chemicals can affect the function of female reproductive organs (<xref ref-type="bibr" rid="bibr23-0748233711422728">Hoyer and Sipes, 1996</xref>). CrVI can traverse the fetoplacental barrier and also transported to offspring through milk (<xref ref-type="bibr" rid="bibr7-0748233711422728">Bailey et al., 2006</xref>; <xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr26-0748233711422728">Junaid et al., 1996</xref>; <xref ref-type="bibr" rid="bibr40-0748233711422728">Rodriguez et al., 2008</xref>; <xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). Earlier studies point out the deleterious effects of CrVI on the structure and function of ovary (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr39-0748233711422728">Rao et al., 2009</xref>). CrVI exposure results in enhanced formation of reactive oxygen species (ROS) including super oxide anions, hydroxyl radical and nitric oxide, decreased cell viability, increased cellular genomic hepatic DNA fragmentation, enhanced intracellular oxidizing states, membrane damage, apoptotic and necrotic cell death (<xref ref-type="bibr" rid="bibr5-0748233711422728">Bagchi et al., 2002</xref>). Previous findings demonstrated that Cr, administrated through drinking water led to abnormal gestational changes in mice and rats, with a decreased number of implantation sites (<xref ref-type="bibr" rid="bibr26-0748233711422728">Junaid et al., 1996</xref>; <xref ref-type="bibr" rid="bibr29-0748233711422728">Kamath et al., 1997</xref>). Pregnant mice exposed to CrVI through drinking water during gestation resulted in increased pre-implantation and post-implantation loss and decreased litter size (<xref ref-type="bibr" rid="bibr57-0748233711422728">Trivedi et al., 1989</xref>). Delayed sexual maturation and reduced fertility were observed in female mice offspring treated with CrVI (<xref ref-type="bibr" rid="bibr1-0748233711422728">Al-Hamood et al., 1998</xref>). Earlier, we have reported the ovotoxic nature of CrVI, where lactational CrVI exposure delayed follicular development and impaired ovarian steroidogenesis (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>). Recently, we have reported the uterotoxic effects of CrVI, where the lactational exposure to CrVI are associated with delayed puberty and oxidative stress (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>).</p>
<p>CrVI can escape from primary contact organs and blood erythrocytes and reach different organs (<xref ref-type="bibr" rid="bibr10-0748233711422728">Barceloux, 1999</xref>; <xref ref-type="bibr" rid="bibr15-0748233711422728">Dayan and Paine, 2001</xref>). CrVI is a well-known oxidizing agent (<xref ref-type="bibr" rid="bibr6-0748233711422728">Bagchi et al., 1995</xref>). In biological systems, after entry into cells, CrVI is rapidly detoxified/reduced to CrIII by intracellular defensive reductant system that includes ascorbate, glutathione (GSH) and cysteine (<xref ref-type="bibr" rid="bibr58-0748233711422728">Valko et al., 2005</xref>). Antioxidant compounds have been used to protect cells from various oxidative damages. Vitamin C is known to be an antistress and a powerful reducing agent and plays an important role in attenuating oxidative damage to the cellular membranes (<xref ref-type="bibr" rid="bibr53-0748233711422728">Sugiyama, 1992</xref>). Vitamin C accounts for 80% of CrVI metabolism in target tissues such as lung, liver and kidney (<xref ref-type="bibr" rid="bibr61-0748233711422728">Zhitkovich, 2005</xref>). In view of the existing background, the present study is aimed to test the hypothesis, ‘Vitamin C prevents the lactational CrVI exposure-induced disruption of ovarian and uterine function in Wistar rats.’</p>
<sec id="section1-0748233711422728" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section2-0748233711422728">
<title>Animals and treatments</title>
<p>Pregnant Wistar rats (<italic>Rattus norvegicus</italic>), 90 days old, were maintained in plastic animal cages in a light controlled room (12-h day light) at 23–25°C and provided with standard rat pellet diet and clean drinking water <italic>ad libitum</italic>.</p>
<p>CrVI doses were selected based on our previous reports (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). Pregnant rats were divided into three groups. At birth, male pups were removed and the litters were culled to four female pups per mother rat. In cases where fewer than four female pups were delivered, additional pups were fostered from other litters. (i) In the control group, the rats received regular drinking water from the day of parturition to day 21 postpartum. (ii) In CrVI-treated group, rats received CrVI (potassium dichromate, 200 mg/L) in drinking water from the day of parturition to day 21 postpartum. (iii) In CrVI + vitamin C group, rats received CrVI (200 mg/L) and vitamin C (ascorbate: 500 mg/L) simultaneously in drinking water from the day of parturition to day 21 postpartum.</p>
<p>During days 1–21 of postnatal life (postnatal day [PND] 1–21), the female pups were exposed to respective CrVI through their mother’s milk. After weaning, on PND 45, female pups from 6 mother rats (<italic>n</italic> = 24; 4 pups/mother) from each group (control, CrVI-200 ppm, CrVI-200 ppm + vitamin C) were killed by decapitation; and their blood, ovary and uterus were collected. The remaining pups were maintained separately and fed with regular drinking water and diet. On PND 65, the rest of the rats (<italic>n</italic> = 24) were killed, and their blood, ovary and uterus were dissected, cleansed and used for biochemical assay. All the chemicals used in the present study were purchased from Sigma Chemical Company, St Louis, USA.</p>
</sec>
<sec id="section3-0748233711422728">
<title>Tissue preparation for enzyme assays</title>
<p>Ovary and uterus were dissected out and washed in ice cold physiological saline repetitively, weighed accurately and homogenized in 0.1 mol/l Tris-HCl buffer, pH 7.4. The protein concentrations of the tissue homogenates were determined by the method of <xref ref-type="bibr" rid="bibr32-0748233711422728">Lowry et al. (1951</xref>) using bovine serum albumin as the standard. The detailed methodology for the antioxidant enzymes and ROS assays were described in our earlier article (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>).</p>
</sec>
<sec id="section4-0748233711422728">
<title>Antioxidant enzymes</title>
<p>SOD activity was estimated according to the method of <xref ref-type="bibr" rid="bibr33-0748233711422728">Marklund and Marklund (1974</xref>). The enzyme activity was expressed as U/mg protein. Catalase (CAT) activity was quantified colorimetrically (<xref ref-type="bibr" rid="bibr50-0748233711422728">Sinha, 1972</xref>) and expressed as mmoles of H<sub>2</sub>O<sub>2</sub> utilized/min/mg protein. Glutathione peroxidase (GPx) activity was determined colorimetrically (<xref ref-type="bibr" rid="bibr41-0748233711422728">Rotruck et al., 1973</xref>) and expressed as U/mg protein. Glutathione-<italic>S</italic>-transferase (GST) activity was determined by estimating the amount of enzyme that catalyzed the conjugation of a known amount of 1-chloro-2,4-dibenzene with GSH (<xref ref-type="bibr" rid="bibr20-0748233711422728">Habig et al., 1974</xref>) and expressed as μmoles of GSH consumed/min/mg protein. Glutathione reductase (GR) activity was assayed colorimetrically (<xref ref-type="bibr" rid="bibr51-0748233711422728">Staal et al., 1969</xref>) and expressed as nmoles of NADPH oxidized/min/mg protein.</p>
</sec>
<sec id="section5-0748233711422728">
<title>Reactive oxygen species</title>
<p>Lipid peroxidation (LPO) was measured by the method of (<xref ref-type="bibr" rid="bibr17-0748233711422728">Devasagayam and Tarachand, 1987</xref>). The results were expressed as nmoles of malondialdehyde (MDA) formed/mg protein. H<sub>2</sub>O<sub>2</sub> production was assessed spectrophotometrically (<xref ref-type="bibr" rid="bibr22-0748233711422728">Holland and Storey, 1981</xref>) and the content was expressed as μmoles of H<sub>2</sub>O<sub>2</sub>/mg protein.</p>
</sec>
<sec id="section6-0748233711422728">
<title>Chromium estimation</title>
<sec id="section7-0748233711422728">
<title>Chromium level in ovary and uterus</title>
<p>Cr levels in ovary and uterus of control and CrVI-exposed rats were estimated as described earlier (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). To provide enough tissue for analysis, ovary and uterus in a dose group were pooled whenever needed. Fifty milligram of tissue was digested in 1 ml of concentrated HNO<sub>3</sub> and 1 ml of perchloric acid over a sand bath until the solution became pale yellow. If the color of the digest was brown, more HNO<sub>3</sub> and perchloric acid were added and the oxidation was repeated. The digest was made up to 1 ml with deionized water. Aliquots of this were used to estimate Cr, using an atomic absorption spectrometer (Perklin Elmer 2380), at 357.8 nm wavelength. The values are expressed as μg/g tissue.</p>
</sec>
<sec id="section8-0748233711422728">
<title>Chromium level in serum</title>
<p>Serum Cr was directly quantified (<xref ref-type="bibr" rid="bibr14-0748233711422728">Davidson and Secrest, 1972</xref>). Serum samples were diluted to the ratio of 1:10 with diluent containing 0.1% Triton and 0.1% HNO<sub>3</sub> in distilled deionized water. Aliquots of this were used to estimate the Cr content, using an atomic absorption spectrometer (Perklin Elmer 2380) at 357.8 nm wavelength. The values are expressed as μg/ml of serum.</p>
</sec>
<sec id="section9-0748233711422728">
<title>Sexual maturation and estrous cycle</title>
<p>Vaginal opening was observed in rats from PND 22, every 24 h to determine the sexual maturation, as this was used as an index to assess the onset of puberty. After the puberty, vaginal smears were examined every morning as described previously (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr46-0748233711422728">Samuel et al., 2011a</xref>, <xref ref-type="bibr" rid="bibr47-0748233711422728">b</xref>). </p>
</sec>
<sec id="section10-0748233711422728">
<title>Radioimmunoassay (RIA) of steroid hormones</title>
<p>Serum levels of estradiol, progesterone and testosterone were estimated by RIA as described earlier (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr46-0748233711422728">Samuel et al., 2011a</xref>, <xref ref-type="bibr" rid="bibr47-0748233711422728">b</xref>). The maximum binding of the estradiol antibody was 37–40%, and the sensitivity of the assay was 0.3 pg/ml. The concentration of estradiol in serum is expressed as pg/ml. The percentage of binding of the testosterone antibody was 36%, and the sensitivity of the assay was 0.3 pg testosterone/ml. Testosterone levels in serum are expressed as ng/ml. The maximum binding of progesterone antibody was 40% and the sensitivity of the assay was 0.3 pg/ml. Progesterone level is expressed as ng/ml.</p>
</sec>
<sec id="section11-0748233711422728">
<title>Radioimmunoassay of peptide hormones</title>
<p>Serum levels of luteinising hormone (LH) and follicle stimulating hormone (FSH) were assayed by RIA as described earlier (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). The maximum binding of the LH antibody was 31.36% and the sensitivity of the assay was 0.2 ng/ml. The maximum binding of FSH antibody was 31% and the sensitivity of the assay was 0.2 ng/ml. LH and FSH levels were expressed as ng/ml.</p>
</sec>
</sec>
<sec id="section12-0748233711422728">
<title>Statistical analysis</title>
<p>Data were statistically analyzed using analysis of variance. When the <italic>F</italic> ratio was statistically significant, the data were subjected to Students Newman-Keul’s test. Values were considered significant at <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="section13-0748233711422728">
<title>Results</title>
<p>Lactational CrVI exposure leads to age-dependent changes in the specific activities of antioxidant enzymes, free radicals and hormones in postnatal rat ovary and uterus and simultaneous vitamin C treatment prevented the toxic effects of CrVI. </p>
<sec id="section14-0748233711422728">
<title>Body, ovary and uterus weight</title>
<p>Lactational CrVI exposure significantly decreased the body weight, ovary weight and uterus weight in both the age groups of CrVI-treated rats. Vitamin C treatment completely prevented the CrVI-induced decrease in body and uterus weight in PND 45 and PND 65 rats; however, vitamin C partially prevented the changes in ovary weight in both PND 45 and PND 65 rats (<xref ref-type="table" rid="table1-0748233711422728">Table 1</xref>).</p>
<table-wrap id="table1-0748233711422728" position="float">
<label>Table 1.</label>
<caption>
<p>Effect of lactational exposure to CrVI on body, ovary and uterus weight in developing rats (PNDs 45 and 65)</p>
</caption>
<graphic alternate-form-of="table1-0748233711422728" xlink:href="10.1177_0748233711422728-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="3">Body weight (g)</th>
<th colspan="3">Ovary weight (mg)</th>
<th colspan="3">Uterus weight (mg)</th>
</tr>
<tr>
<th>Age</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI + Vit. C</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI +  Vit. C</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI + Vit. C</th>
</tr>
</thead>
<tbody>
<tr>
<td>PND 45</td>
<td>69 ± 3.6</td>
<td>51 ± 3.8<sup><xref ref-type="table-fn" rid="table-fn3-0748233711422728">a</xref></sup>
</td>
<td>63 ± 2.7</td>
<td>54 ± 2.2</td>
<td>41 ± 1.9<sup><xref ref-type="table-fn" rid="table-fn3-0748233711422728">a</xref></sup>
</td>
<td>50 ± 2.4<sup><xref ref-type="table-fn" rid="table-fn4-0748233711422728">b</xref></sup>
</td>
<td>287 ± 12.4</td>
<td>256 ± 15.9<sup><xref ref-type="table-fn" rid="table-fn3-0748233711422728">a</xref></sup>
</td>
<td>266 ± 13.7</td>
</tr>
<tr>
<td>PND 65</td>
<td>98 ± 7.2</td>
<td>65 ± 5.3<sup><xref ref-type="table-fn" rid="table-fn3-0748233711422728">a</xref></sup>
</td>
<td>85 ± 5.9</td>
<td>62 ± 3.8</td>
<td>52 ± 4.7<sup><xref ref-type="table-fn" rid="table-fn3-0748233711422728">a</xref></sup>
</td>
<td>64 ± 5.2<sup><xref ref-type="table-fn" rid="table-fn4-0748233711422728">b</xref></sup>
</td>
<td>389 ± 20.2</td>
<td>328 ± 26.6<sup><xref ref-type="table-fn" rid="table-fn3-0748233711422728">a</xref></sup>
</td>
<td>354 ± 21.5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711422728">
<p>CrVI: hexavalent chromium, PND: postnatal day, Vit. C: vitamin C.</p>
</fn>
<fn id="table-fn2-0748233711422728">
<p>Each value represents the mean and SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05.</p>
</fn>
<fn id="table-fn3-0748233711422728">
<p>
<sup>a</sup>Control versus experiment.</p>
</fn>
<fn id="table-fn4-0748233711422728">
<p>
<sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section15-0748233711422728">
<title>Chromium content in serum, ovary and uterus</title>
<p>In order to check, whether the decreased body, ovary and uterus weight is associated with the bioavailability of Cr, we have estimated the levels of Cr in serum, ovary and uterus of experimental offspring (<xref ref-type="table" rid="table2-0748233711422728">Table 2</xref>). Cr content was significantly different between serum, ovary and uterus at basal conditions. Serum, ovary and uterus of Cr-exposed animals have higher Cr content than control animals. Vitamin C treatment prevented accumulation of Cr partially in PND 45 rats and completely in PND 65 rats.</p>
<table-wrap id="table2-0748233711422728" position="float">
<label>Table 2.</label>
<caption>
<p>Effect of lactational exposure to CrVI on the bioavailability of chromium in the serum, ovary and uterus in developing rats (PNDs 45 and 65)</p>
</caption>
<graphic alternate-form-of="table2-0748233711422728" xlink:href="10.1177_0748233711422728-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="3">Serum level (μg/ml)</th>
<th colspan="3">Ovary level (μg/g)</th>
<th colspan="3">Uterus level (μg/g)</th>
</tr>
<tr>
<th>Age</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI + Vit. C</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI + Vit. C</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI + Vit. C</th>
</tr>
</thead>
<tbody>
<tr>
<td>PND 45</td>
<td>0.13 ± 0.02</td>
<td>0.35 ± 0.05<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref></sup>
</td>
<td>0.29 ± 0.02<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref></sup>
</td>
<td>0.38 ± 0.04</td>
<td>0.62 ± 0.07</td>
<td>0.43 ± 0.04<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422728">b</xref></sup>
</td>
<td>0.33 ± 0.03</td>
<td>0.58 ± 0.04<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref></sup>
</td>
<td>0.43 ± 0.04<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref>,<xref ref-type="table-fn" rid="table-fn8-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td>PND 65</td>
<td>0.11 ± 0.01</td>
<td>0.19 ± 0.01<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref></sup>
</td>
<td>0.15 ± 0.02<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref>,<xref ref-type="table-fn" rid="table-fn8-0748233711422728">b</xref></sup>
</td>
<td>0.31 ± 0.04</td>
<td>0.59 ± 0.06<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref></sup>
</td>
<td>0.33 ± 0.05<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422728">b</xref></sup>
</td>
<td>0.32 ± 0.05</td>
<td>0.53 ± 0.05<sup><xref ref-type="table-fn" rid="table-fn7-0748233711422728">a</xref></sup>
</td>
<td>0.39 ± 0.03<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422728">b</xref></sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0748233711422728">
<p>CrVI: hexavalent chromium, PND: postnatal day, Vit. C: vitamin C.</p>
</fn>
<fn id="table-fn6-0748233711422728">
<p>Each value represents the mean and SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05.</p>
</fn>
<fn id="table-fn7-0748233711422728">
<p>
<sup>a</sup>Control versus experiment.</p>
</fn>
<fn id="table-fn8-0748233711422728">
<p>
<sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section16-0748233711422728">
<title>Sexual maturation</title>
<p>Vaginal opening has been used as an index of sexual maturation. To evaluate the effect of CrVI on the sexual maturation, we have examined the vaginal opening every 24 h in the experimental rats from PND 22 onwards (<xref ref-type="fig" rid="fig1-0748233711422728">Figure 1</xref>). CrVI exposure significantly delayed the sexual maturation in postnatal rats, while vitamin C restored the CrVI exposure-induced delay in sexual maturation. </p>
<fig id="fig1-0748233711422728" position="float">
<label>Figure 1.</label>
<caption>
<p>Effect of lactational exposure to hexavalent chromium (CrVI) on sexual maturation in developing rats (postnatal days [PNDs] 45 and 65). Each bar represents the mean and the vertical line above denotes the SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05; <sup>a</sup>control versus experiment; <sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</caption>
<graphic xlink:href="10.1177_0748233711422728-fig1.tif"/>
</fig>
</sec>
<sec id="section17-0748233711422728">
<title>Estrous cyclicity</title>
<p>In order to evaluate the effect of CrVI on the duration of estrous cycle, vaginal cytology was determined daily (<xref ref-type="fig" rid="fig2-0748233711422728">Figure 2</xref>). CrVI exposure significantly extended the estrous cycle in diestrous stage when compared to control rats. CrVI exposure did not alter proestrous, estrous and metestrous phases of estrous cycle. Vitamin C prevented the extension of estrous cycle in CrVI-exposed rats. </p>
<fig id="fig2-0748233711422728" position="float">
<label>Figure 2.</label>
<caption>
<p>Effect of lactational exposure to hexavalent chromium (CrVI) on estrous cycle in developing rats (postnatal days [PNDs] 45 and 65). Each bar represents the mean and the vertical line above denotes the SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05; <sup>a</sup>control versus experiment; <sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</caption>
<graphic xlink:href="10.1177_0748233711422728-fig2.tif"/>
</fig>
</sec>
<sec id="section18-0748233711422728">
<title>Antioxidant enzymes</title>
<p>Effect of CrVI on the specific activities of different antioxidant enzymes in rat ovary and uterus are described in <xref ref-type="fig" rid="fig3-0748233711422728">Figures 3</xref>(a–e) and <xref ref-type="fig" rid="fig4-0748233711422728">4</xref> (a–e). CrVI exposure decreased the specific activities of SOD, CAT, GPx, GR and GST in the rat ovary and uterus of PND 45 and PND 65 rats. Vitamin C treatment partially prevented the CrVI exposure-induced decrease in ovarian SOD, CAT, GPx and GR levels in PND 45 rats, while it is completely restored in PND 65 rats. However, CrVI exposure-induced decrease in uterine antioxidants SOD, CAT, GPx, GST and GR were partially prevented by vitamin C treatment in PND 45 and PND 65 rats.</p>
<fig id="fig3-0748233711422728" position="float">
<label>Figure 3.</label>
<caption>
<p>Effect of lactational exposure to hexavalent chromium (CrVI) on the specific activities of ovarian superoxide dismutase (SOD; a), catalase (b), glutathione peroxidase (GPx; c), glutathione-<italic>S</italic>-transferase (GST; d) and glutathione reductase (GR; e). Each bar represents the mean and the vertical line above denotes the SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05; <sup>a</sup>control versus experiment; <sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</caption>
<graphic xlink:href="10.1177_0748233711422728-fig3.tif"/>
</fig>
<fig id="fig4-0748233711422728" position="float">
<label>Figure 4.</label>
<caption>
<p>Effect of lactational exposure to hexavalent chromium (CrVI) on the specific activities of uterine superoxide dismutase (SOD; a), catalase (b), glutathione peroxidase (GPx; c), glutathione-<italic>S</italic>-transferase (GST; d) and glutathione reductase (GR; e). Each bar represents the mean and the vertical line above denotes the SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05; <sup>a</sup>control versus experiment; <sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</caption>
<graphic xlink:href="10.1177_0748233711422728-fig4.tif"/>
</fig>
</sec>
<sec id="section19-0748233711422728">
<title>Lipid peroxidation and H<sub>2</sub>O<sub>2</sub> concentration </title>
<p>
<xref ref-type="fig" rid="fig5-0748233711422728">Figures 5</xref> (a, b) and <xref ref-type="fig" rid="fig6-0748233711422728">6</xref> (a, b) represent the levels of MDA and H<sub>2</sub>O<sub>2</sub> in control, CrVI with or without vitamin C treated ovary and uterus of PND 45 and PND 65 rats. Increased concentrations of LPO and H<sub>2</sub>O<sub>2</sub> generation were observed in CrVI-treated ovaries and uterus of PND 45 and PND 65 rats. However, simultaneous vitamin C treatment partially prevented the CrVI-exposure-induced increase in LPO and H<sub>2</sub>O<sub>2</sub> levels in PND 45 and PND 65 uterus and PND 65 ovary, while it is completely prevented in PND 65 rat ovary.</p>
<fig id="fig5-0748233711422728" position="float">
<label>Figure 5.</label>
<caption>
<p>Effect of lactational exposure to hexavalent chromium (CrVI) on ovarian lipid peroxidation (LPO; a) and H<sub>2</sub>O<sub>2</sub> (b). Each bar represents the mean and the vertical line above denotes the SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05; <sup>a</sup>control versus experiment; <sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</caption>
<graphic xlink:href="10.1177_0748233711422728-fig5.tif"/>
</fig>
<fig id="fig6-0748233711422728" position="float">
<label>Figure 6.</label>
<caption>
<p>Effect of lactational exposure to hexavalent chromium (CrVI) on uterine lipid peroxidation (LPO; a) and H<sub>2</sub>O<sub>2</sub> (b). Each bar represents the mean and the vertical line above denotes the SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05; <sup>a</sup>control versus experiment; <sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</caption>
<graphic xlink:href="10.1177_0748233711422728-fig6.tif"/>
</fig>
</sec>
<sec id="section20-0748233711422728">
<title>Serum hormones</title>
<p>
<xref ref-type="table" rid="table3-0748233711422728">Table 3</xref> represents circulating levels of steroid and pituitary hormones in postnatal rats exposed to CrVI and CrVI along with vitamin C. CrVI exposure decreased steroid hormones in both PND 45 and PND 65 rats, while vitamin C prevented the CrVI-exposure-induced decrease in steroid hormone levels. Pituitary hormones LH and FSH showed a varied pattern, FSH and LH significantly increased in PND 45 rats, while PND 65 rats did not show any significant difference between control and CrVI-exposed rats. Vitamin C treatment prevented the CrVI-exposure-induced increase in LH and FSH levels. </p>
<table-wrap id="table3-0748233711422728" position="float">
<label>Table 3.</label>
<caption>
<p>Effect of lactational exposure to CrVI on circulating levels of steroid and pituitary hormones in developing rats (PNDs 45 and 65)</p>
</caption>
<graphic alternate-form-of="table3-0748233711422728" xlink:href="10.1177_0748233711422728-table3.tif"/>
<table>
<thead>
<tr>
<th>Hormone</th>
<th>Age</th>
<th>Control</th>
<th>CrVI</th>
<th>CrVI + Vit. C</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">Testosterone</td>
<td>PND 45</td>
<td>0.94 ± 0.07</td>
<td>0.45 ± 0.04<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>0.89 ± 0.03<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td>PND 65</td>
<td>1.07 ± 0.08</td>
<td>0.56 ± 0.05<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>0.93 ± 0.07<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td rowspan="2">Estradiol</td>
<td>PND 45</td>
<td>43.8 ± 4.0</td>
<td>24.1 ± 2.3<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>46.7 ± 4.5<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td>PND 65</td>
<td>40.9 ± 3.5</td>
<td>27.3 ± 2.1<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>38.9 ± 4.7<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td rowspan="2">Progesterone</td>
<td>PND 45</td>
<td>6.42 ± 0.45</td>
<td>3.70 ± 0.68<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>5.53 ± 0.74<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td>PND 65</td>
<td>9.01 ± 0.85</td>
<td>5.21 ± 0.68<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>8.42 ± 0.82<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td rowspan="2">LH</td>
<td>PND 45</td>
<td>7.35 ± 0.85</td>
<td>9.34 ± 1.21<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>7.90 ± 1.40</td>
</tr>
<tr>
<td>PND 65</td>
<td>5.86 ± 0.55</td>
<td>7.49 ± 0.95</td>
<td>6.97 ± 0.77</td>
</tr>
<tr>
<td rowspan="2">FSH</td>
<td>PND 45</td>
<td>10.0 ± 1.12</td>
<td>16.47 ± 1.58<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>11.6 ± 1.74<sup><xref ref-type="table-fn" rid="table-fn12-0748233711422728">b</xref></sup>
</td>
</tr>
<tr>
<td>PND 65</td>
<td>9.30 ± 0.75</td>
<td>10.1 ± 1.28<sup><xref ref-type="table-fn" rid="table-fn11-0748233711422728">a</xref></sup>
</td>
<td>10.4 ± 1.84</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-0748233711422728">
<p>CrVI: hexavalent chromium, FSH: follicle stimulating hormone, LH: luteinising hormone, PND: postnatal day, Vit. C: vitamin C.</p>
</fn>
<fn id="table-fn10-0748233711422728">
<p> Each value represents the mean and SEM of 24 female rats (from 6 mothers). See Materials and methods section for experimental details; statistical significance of difference among groups at <italic>p</italic> &lt; 0.05.</p>
</fn>
<fn id="table-fn11-0748233711422728">
<p>
<sup>a</sup>Control versus experiment.</p>
</fn>
<fn id="table-fn12-0748233711422728">
<p>
<sup>b</sup>CrVI versus CrVI + vitamin C.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section21-0748233711422728">
<title>Discussion</title>
<p>There is growing concern about the increasing prevalence of various abnormalities of the reproductive system in humans. Since the reproductive process is critical for perpetuation of any organism, factors or agents that alter or disrupt, this process can have devastating consequences. CrVI is the established endocrine disruptor reported to disturb the reproductive process in both males (<xref ref-type="bibr" rid="bibr3-0748233711422728">Aruldhas et al., 2005</xref>) and females (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr39-0748233711422728">Rao et al., 2009</xref>; <xref ref-type="bibr" rid="bibr40-0748233711422728">Rodriguez et al., 2008</xref>; <xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). The purpose of this study was to investigate the toxic effects of CrVI in two major female reproductive organs, viz., ovary and uterus and to examine the possible beneficial role of vitamin C in preventing CrVI-induced female reproductive toxicity. In the present study, body and organ (ovary and uterus) weight were decreased significantly. This was consistent with our earlier reports (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>) and also with others (<xref ref-type="bibr" rid="bibr1-0748233711422728">Al-Hamood et al., 1998</xref>; <xref ref-type="bibr" rid="bibr39-0748233711422728">Rao et al., 2009</xref>). The failure of postnatal rats exposed to CrVI through mother’s milk to gain body weight may be due to decreased feed intake, malabsorption of nutrients from the gastrointestinal tract and impaired feed conversion efficiency (<xref ref-type="bibr" rid="bibr8-0748233711422728">Ball and Chhabra, 1981</xref>). Cr was shown to be an essential micronutrient required for normal carbohydrate and lipid metabolism and acts as a cofactor for enzymes like cytochrome C, phosphoglucomutase and was involved in nucleic acid metabolism (<xref ref-type="bibr" rid="bibr34-0748233711422728">Mertz, 1993</xref>). The observed decrease in body and organ (ovary and uterus) weight may be due to the influence of CrVI on the intermediary metabolism. Vitamin C treatment prevented the CrVI-exposure-induced reduction in body and uterus weight in both PND 45 and PND 65 rats. However, the toxic effects of CrVI on ovary was partially prevented by vitamin C. Earlier, we have reported the ovotoxic and uterotoxic nature of CrVI, where CrVI treatment resulted in permanent damage to ovarian cell population (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>) with extended estrous cycle (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>).</p>
<p>The involvement of oxidative stress was found in heavy metal toxicity (<xref ref-type="bibr" rid="bibr54-0748233711422728">Susa et al., 1996</xref>). Cr-induced ROS can damage the cellular element in its target organs (<xref ref-type="bibr" rid="bibr4-0748233711422728">Bagchi et al., 2001</xref>). CrVI produces excess ROS including superoxide anion, singlet oxygen and hydroxyl radicals (<xref ref-type="bibr" rid="bibr30-0748233711422728">Kawanishi et al., 1986</xref>). CrVI-exposure-induced impairment of the pituitary-ovarian axis in Teleost was reported (<xref ref-type="bibr" rid="bibr36-0748233711422728">Mishra and Mohanty, 2010</xref>). CrVI-induced oxidative stress in mouse ovary (<xref ref-type="bibr" rid="bibr39-0748233711422728">Rao et al., 2009</xref>) and rat uterus (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>) were known. Results from the present investigation indicate the induction of oxidative stress in the ovary and uterus of rats exposed to CrVI through mother’s milk, as there was a significant increase in the concentration of H<sub>2</sub>O<sub>2</sub> and LPO with subnormal activity of the most of the antioxidant enzymes tested. As a transition metal, Cr can replace iron and copper in Fenton reaction and generate hydroxyl radical which is able to initiate LPO, leading to increased MDA concentration, one of the byproducts of LPO (<xref ref-type="bibr" rid="bibr18-0748233711422728">Dey et al., 2003</xref>; <xref ref-type="bibr" rid="bibr28-0748233711422728">Kalahasthi et al., 2006</xref>; <xref ref-type="bibr" rid="bibr48-0748233711422728">Sawicka et al., 2010</xref>). The increase in H<sub>2</sub>O<sub>2</sub> might induce the peroxidation of polyunsaturated fatty acids and lead to the formation of MDA. Higher concentration of MDA in serum of chrome-plating industry workers (<xref ref-type="bibr" rid="bibr24-0748233711422728">Huang et al., 1999</xref>) and in mouse ovary exposed to CrVI (<xref ref-type="bibr" rid="bibr39-0748233711422728">Rao et al., 2009</xref>) further highlights the involvement of oxidative stress in Cr-induced toxicity. Recently, we showed higher levels of MDA in rat uterus exposed to CrVI (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). Vitamin C treatment prevented the CrVI-exposure-induced oxidative stress and LPO in both ovary and uterus. Data from the present study revealed decreased levels of serum testosterone, estradiol and progesterone. Estrogen deficiency was shown to be associated with oxidative stress (<xref ref-type="bibr" rid="bibr37-0748233711422728">Muthusami et al., 2005</xref>). Thus, the impaired level of serum steroids observed in the present study might have led to increased level of MDA in ovary and uterus.</p>
<p>The levels of MDA were increased in both ovary and uterus of PND 45 and PND 65 rats exposed to CrVI through mother’s milk. The observed increase in LPO was many folds higher in ovary than uterus. The increase in LPO may also be due to decreased activities of SOD and CAT, the free radical scavenging enzymes. The enzyme SOD catalyses dismutation of superoxide radical, leading to the formation of H<sub>2</sub>O<sub>2</sub>, which inturn was detoxified by the enzymes GPx and CAT (<xref ref-type="bibr" rid="bibr42-0748233711422728">Rzeuski et al., 1998</xref>). The present study also showed decreased levels of SOD and CAT in both ovary and uterus of PND 45 and PND 65 rats exposed to CrVI and the decrease in SOD activity may result in more accumulation of O<sub>2</sub>
<sup>−</sup>, which in turn may inhibit other antioxidant enzymes. The decreased activities of SOD and CAT in the present study were concomitant with our previous reports (<xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>) and with that of <xref ref-type="bibr" rid="bibr39-0748233711422728">Rao et al. (2009</xref>). CAT is the main scavenger of H<sub>2</sub>O<sub>2</sub> at high concentration. Along with CAT, GPx is also involved in scavenging H<sub>2</sub>O<sub>2</sub> and thereby protects cell membrane from LPO (<xref ref-type="bibr" rid="bibr44-0748233711422728">Samanta et al., 1999</xref>).</p>
<p>The present study indicates that CrVI-exposed offspring exhibited delayed sexual maturation with extended estrous cycle when compared to control rats. The risk of damage to the ovarian follicle cell population from Cr depends mainly on the accessibility of Cr to the follicles. After entering the body by the oral route, CrVI reduced to CrIII by fluids in the digestive tract and then it can be sequestered by intestinal bacteria (<xref ref-type="bibr" rid="bibr35-0748233711422728">Metze et al., 2005</xref>). CrVI that escapes reduction in digestive tract could also be reduced in the blood of the portal vein system and then in liver (<xref ref-type="bibr" rid="bibr16-0748233711422728">De Flora et al., 1997</xref>). In spite of these protective mechanisms, CrVI can reach several other reproductive tissues, where it can be accumulated. In the present study, the post natal rats exposed to CrVI through mother’s milk had increased levels of Cr in serum, ovary and uterus. Difference between ovary and uterine Cr accumulation could be due to distinctive properties of each tissue. Earlier, we have reported that higher accumulation of Cr reduced ovarian follicular cell population (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>). In the present study, the observed oxidative stress and the Cr accumulation in target tissues might have delayed sexual maturation. CrVI is reported to arrest the cell cycle at G2/M phase along with decreased CAT levels in lung epithelial cells (<xref ref-type="bibr" rid="bibr60-0748233711422728">Zhang et al., 2001</xref>). A similar mechanism might operate in the present study, which could have contributed to the decrease in ovarian follicle number through arrest in G2/M cell cycle in CrVI treated rats. Vitamin C treatment partially prevented the CrVI-exposure-induced accumulation of Cr in serum, ovary and uterus of PND 45 and PND 65 rats. The present study also showed decreased levels of sex steroid hormone levels. The decreased levels of steroid hormones observed in the present investigation might be due to the CrVI-induced decrease in the number of ovarian follicles and the associated oxidative stress. Estradiol is not only associated with follicular maturation and oxidative stress but also regulates LH and FSH from the pituitary through positive and negative feedback on the hypothalamus and pituitary (<xref ref-type="bibr" rid="bibr23-0748233711422728">Hoyer and Sipes, 1996</xref>). Earlier, we have reported the decreased expression of steroidogenic genes in ovarian cells exposed to CrVI (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>). We have also reported the toxic effects of CrVI on developing rat ovary and uterus (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr40-0748233711422728">Rodriguez et al., 2008</xref>; <xref ref-type="bibr" rid="bibr47-0748233711422728">Samuel et al., 2011b</xref>). The CrVI exposure-induced impairment of steroidogenic mechanisms might have led to decreased synthesis of steroid hormones despite increase in the FSH levels. This may be the reason behind the delayed sexual maturation observed in the present investigation. The effects of LH and FSH are mediated by their respective receptors LHR and FSHR. Earlier, we have reported the CrVI reduced LHR and FSHR levels both <italic>in vivo</italic> (<xref ref-type="bibr" rid="bibr45-0748233711422728">Samuel, 2001</xref>) and <italic>in vitro</italic> (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr40-0748233711422728">Rodriguez et al., 2008</xref>). Collectively, these findings indicate the deleterious effects of CrVI on female reproductive system. </p>
<p>The protective effect of vitamin C on heavy metal toxicity is well documented via its detoxifying effects and free radical scavenging mechanisms (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>; <xref ref-type="bibr" rid="bibr27-0748233711422728">Kaderabkova et al., 1997</xref>; <xref ref-type="bibr" rid="bibr52-0748233711422728">Subramanian et al., 2006</xref>; <xref ref-type="bibr" rid="bibr55-0748233711422728">Suzuki, 1990</xref>). Earlier, we have reported the beneficial effect of vitamin C in CrVI-induced ovotoxicity (<xref ref-type="bibr" rid="bibr9-0748233711422728">Banu et al., 2008</xref>). Recently, vitamin C has been shown to protect thyroid gland from toxic effects of CrVI (<xref ref-type="bibr" rid="bibr38-0748233711422728">Qureshi and Mahmood, 2010</xref>). Vitamin C is an essential nutrient that functions as a nonenzymatic antioxidant in the cytosol. Once CrVI enters into the cells, it is rapidly reduced to CrIII by vitamin C, GSH and other antioxidants (<xref ref-type="bibr" rid="bibr31-0748233711422728">Liu et al., 2005</xref>). During this reduction process, enormous amount of ROS is formed and are scavenged by antioxidants to protect cells from oxidative stress (<xref ref-type="bibr" rid="bibr58-0748233711422728">Valko et al., 2005</xref>). In the present study, supplementation of vitamin C along with CrVI in rats exhibited protective effect in both ovary and uterus, as most of the parameters studied did not exhibit variation in comparison to control. </p>
<p>The present study reported the beneficial effects of vitamin C on ovarian and uterine toxicity induced by CrVI exposure through mother’s milk. The present study design simulated the work environment where pregnant and lactating women were exposed to CrVI. The results from the present investigation revealed that lactational CrVI exposure affects the ovary and uterus and delayed sexual maturation of postnatal rats and the toxic effects were prevented by simultaneous supplementation of vitamin C. The present study reports the mitigative effects of vitamin C on CrVI-induced delay in ovarian and uterine antioxidant system and also on sexual maturation. Large-scale controlled studies are needed in order to support the beneficial effects of vitamin C in pregnant and lactating women who are all in potential danger of occupational CrVI exposure.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0748233711422728">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Hamood</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Elbetieha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bataineh</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Sexual maturation and fertility of male and female mice exposed prenatally and postnatally to trivalent and hexavalent chromium compounds</article-title>. <source>Reproduction Fertility and Development</source> <volume>10</volume>(<issue>2</issue>): <fpage>179</fpage>–<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>RA</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Chromium in the prevention and control of diabetes</article-title>. <source>Diabetes &amp; Metabolism</source> <volume>26</volume>(<issue>1</issue>): <fpage>22</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aruldhas</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sekar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vengatesh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chandrahasan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Govindarajulu</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>Chronic chromium exposure-induced changes in testicular histoarchitecture are associated with oxidative stress: study in a non-human primate (Macaca radiata Geoffroy)</article-title>. <source>Human Reproduction</source> <volume>20</volume>(<issue>10</issue>): <fpage>2801</fpage>–<lpage>2813</lpage>.</citation>
</ref>
<ref id="bibr4-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bagchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stohs</surname>
<given-names>SJ</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene</article-title>. <source>Molecular and Cellular Biochemistry</source> <volume>222</volume>(<issue>1-2</issue>): <fpage>149</fpage>–<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Balmoori</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bagchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Stohs</surname>
<given-names>SJ</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative stress and tissue damage in the liver and brain tissues of mice</article-title>. <source>Toxicology</source> <volume>175</volume>(<issue>1-3</issue>): <fpage>73</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hassoun</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Bagchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stohs</surname>
<given-names>SJ</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats</article-title>. <source>Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology</source> <volume>110</volume>: <fpage>177</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Boohaker</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Sawyer</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Behling</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Rasco</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Jernigan</surname>
<given-names>JJ</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring</article-title>. <source>Birth Defects Research Part B, Developmental and Reproductive Toxicology</source> <volume>77</volume>: <fpage>244</fpage>–<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ball</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Chhabra</surname>
<given-names>RS</given-names>
</name>
</person-group> (<year>1981</year>) <article-title>Intestinal absorption of nutrients in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title>. <source>Journal of Toxicology and Environmental Health</source> <volume>8</volume>: <fpage>629</fpage>–<lpage>638</lpage>.</citation>
</ref>
<ref id="bibr9-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banu</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Arosh</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Burghardt</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Aruldhas</surname>
<given-names>MM</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Lactational exposure to hexavalent chromium delays puberty by impairing ovarian development, steroidogenesis and pituitary hormone synthesis in developing Wistar rats</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>232</volume>: <fpage>180</fpage>–<lpage>189</lpage>.</citation>
</ref>
<ref id="bibr10-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barceloux</surname>
<given-names>DG</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Chromium</article-title>. <source>Journal of Toxicology: Clinical Toxicology</source> <volume>37</volume>: <fpage>173</fpage>–<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burrows</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>1978</year>) <article-title>Chromium and the skin</article-title>. <source>The British Journal of Dermatology</source> <volume>99</volume>: <fpage>587</fpage>–<lpage>595</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711422728">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rai</surname>
<given-names>UN</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Bioremediation of Cr from water and soil by vascular aquatic plants</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Kruger</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>JR</given-names>
</name>
</person-group> (eds) <source>Phytoremediation of soil and water contaminants, Symposium Series</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Chemical Society</publisher-name>, <fpage>274</fpage>–<lpage>282</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Kargacin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1993</year>) <article-title>Mechanisms of chromium carcinogenicity and toxicity</article-title>. <source>Critical Reviews in Toxicology</source> <volume>23</volume>: <fpage>255</fpage>–<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davidson</surname>
<given-names>IW</given-names>
</name>
<name>
<surname>Secrest</surname>
<given-names>WL</given-names>
</name>
</person-group> (<year>1972</year>) <article-title>Determination of chromium in biological materials by atomic absorption spectrometry using a graphite furnace atomizer</article-title>. <source>Analytical Chemistry</source> <volume>44</volume>: <fpage>1808</fpage>–<lpage>1813</lpage>.</citation>
</ref>
<ref id="bibr15-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dayan</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Paine</surname>
<given-names>AJ</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000</article-title>. <source>Human and Experimental Toxicology</source> <volume>20</volume>: <fpage>439</fpage>–<lpage>451</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Flora</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Camoirano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bagnasco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bennicelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Kerger</surname>
<given-names>BD</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity</article-title>. <source>Carcinogenesis</source> <volume>18</volume>: <fpage>531</fpage>–<lpage>537</lpage>.</citation>
</ref>
<ref id="bibr17-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devasagayam</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Tarachand</surname>
<given-names>U</given-names>
</name>
</person-group> (<year>1987</year>) <article-title>Decreased lipid peroxidation in the rat kidney during gestation</article-title>. <source>Biochemical and Biophysical Research Communications</source> <volume>145</volume>: <fpage>134</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dey</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Alpha-tocopherol supplementation on chromium toxicity: a study on rat liver and kidney cell membrane</article-title>. <source>Journal of Environmental Science (China)</source> <volume>15</volume>: <fpage>356</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr19-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greene</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Riederer</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Marcus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lkhasuren</surname>
<given-names>O</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Associations of fertility and pregnancy outcomes with leather tannery work in Mongolia: a pilot study</article-title>. <source>International Journal of</source> <source>Occupational and Environmental Health</source> <volume>16</volume>: <fpage>60</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr20-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habig</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Pabst</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jakoby</surname>
<given-names>WB</given-names>
</name>
</person-group> (<year>1974</year>) <article-title>Glutathione S-transferases. The first enzymatic step in mercapturic acid formation</article-title>. <source>The Journal of Biological Chemistry</source> <volume>249</volume>: <fpage>7130</fpage>–<lpage>7139</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halasova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Matakova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kavcova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Musak</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Letkova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Adamkov</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Human lung cancer and hexavalent chromium exposure</article-title>. <source>Neuroendocrinology Letters</source> <volume>30</volume>(<issue>suppl 1</issue>): <fpage>182</fpage>–<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holland</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Storey</surname>
<given-names>BT</given-names>
</name>
</person-group> (<year>1981</year>) <article-title>Oxygen metabolism of mammalian spermatozoa. Generation of hydrogen peroxide by rabbit epididymal spermatozoa</article-title>. <source>The Biochemistry Journal</source> <volume>198</volume>: <fpage>273</fpage>–<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoyer</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Sipes</surname>
<given-names>IG</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Assessment of follicle destruction in chemical-induced ovarian toxicity</article-title>. <source>Annual Reviews in Pharmacology and Toxicology</source> <volume>36</volume>: <fpage>307</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>TH</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Lipid peroxidation in workers exposed to hexavalent chromium</article-title>. <source>Journal of Toxicology and Environmental Health Part A</source> <volume>56</volume>: <fpage>235</fpage>–<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jendryczko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Drozdz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Magner</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>1984</year>) <article-title>Preliminary studies of chromium concentration in the myometrium in the third trimester of pregnancy, in chorionic tissue in the first trimester and in the blood of pregnant women</article-title>. <source>Ginekologia Polska</source> <volume>55</volume>: <fpage>691</fpage>–<lpage>694</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Junaid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>DK</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Embryo- and fetotoxicity of chromium in pregestationally exposed mice</article-title>. <source>Bulletin of Environmental Contamination and Toxicology</source> <volume>57</volume>: <fpage>327</fpage>–<lpage>334</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaderabkova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Racek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kohout</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Holecek</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Senft</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krejcova</surname>
<given-names>I</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>The effect of antioxidant therapy on indicators of activity of free radicals in workers exposed to risks of styrene</article-title>. <source>Vnitrni Lekarstvi</source> <volume>43</volume>: <fpage>388</fpage>–<lpage>391</lpage>.</citation>
</ref>
<ref id="bibr28-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalahasthi</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>MK</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Effect of chromium(VI) on the status of plasma lipid peroxidation and erythrocyte antioxidant enzymes in chromium plating workers</article-title>. <source>Chemico-Biological Interaction</source> <volume>164</volume>: <fpage>192</fpage>–<lpage>199</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Stoecker</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Davis-Whitenack</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Adeleye</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Sangiah</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Absorption, retention and urinary excretion of chromium-51 in rats pretreated with indomethacin and dosed with dimethylprostaglandin E2, misoprostol or prostacyclin</article-title>. <source>Journal of Nutrition</source> <volume>127</volume>: <fpage>478</fpage>–<lpage>482</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawanishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>1986</year>) <article-title>Mechanism of DNA cleavage induced by sodium chromate(VI) in the presence of hydrogen peroxide</article-title>. <source>The Journal of Biological Chemistry</source> <volume>261</volume>: <fpage>5952</fpage>–<lpage>5958</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>He</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Remediation of Cr(VI) in solution using vitamin C</article-title>. <source>Journal of Zhejiang University</source> <source>Science</source> <volume>6</volume>: <fpage>540</fpage>–<lpage>542</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowry</surname>
<given-names>OH</given-names>
</name>
<name>
<surname>Rosebrough</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Farr</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>RJ</given-names>
</name>
</person-group> (<year>1951</year>) <article-title>Protein measurement with the Folin phenol reagent</article-title>. <source>Journal of Biological Chemistry</source> <volume>193</volume>: <fpage>265</fpage>–<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marklund</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marklund</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>1974</year>) <article-title>Involvement of super oxide anion radical in the auto oxidation of pyrogallol and a convenient assay for super oxide dismutase</article-title>. <source>European Journal of Biochemistry</source> <volume>47</volume>: <fpage>469</fpage>–<lpage>474</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mertz</surname>
<given-names>W</given-names>
</name>
</person-group> (<year>1993</year>) <article-title>Chromium in human nutrition: a review</article-title>. <source>Journal of Nutrition</source> <volume>123</volume>: <fpage>626</fpage>–<lpage>633</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711422728">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Metze</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jakubowski</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Klockow</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Speciation of chromium in environment and food</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Cornelis</surname>
<given-names>R</given-names>
</name>
</person-group> (ed.) <source>Handbook of elemental speciation II: species in the environment, food, medicine and occupational health</source>. <publisher-loc>Sussex, UK</publisher-loc>: <publisher-name>John Wiley</publisher-name>, <fpage>120</fpage>–<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Mohanty</surname>
<given-names>B</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Effect of sublethal hexavalent chromium exposure on the pituitary-ovarian axis of a teleost, Channa punctatus (Bloch) [published online ahead of print November 29, 2010]</article-title>. <source>Environmental Toxicology</source>.</citation>
</ref>
<ref id="bibr37-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthusami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ramachandran</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Muthusamy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vasudevan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Subramaniam</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats</article-title>. <source>Clinica Chimica Acta</source> <volume>360</volume>: <fpage>81</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qureshi</surname>
<given-names>IZ</given-names>
</name>
<name>
<surname>Mahmood</surname>
<given-names>T</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Prospective role of ascorbic acid (vitamin C) in attenuating hexavalent chromium-induced functional and cellular damage in rat thyroid</article-title>. <source>Toxicology and Industrial Health</source> <volume>26</volume>: <fpage>349</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr39-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Chawla</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>SR</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Protective role of vitamin E on nickel and/or chromium induced oxidative stress in the mouse ovary</article-title>. <source>Food and Chemical Toxicology</source> <volume>47</volume>: <fpage>1368</fpage>–<lpage>1371</lpage>.</citation>
</ref>
<ref id="bibr40-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Arosh</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aruldhas</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Banu</surname>
<given-names>SK</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Chromium toxicity induces ovarian follicular developmental arrest, apoptosis, and deregulated steroidogenesis: vitamin c restores follicular survival and function</article-title>. <source>Biology of Reproduction</source> <volume>77</volume>: <fpage>215</fpage>.</citation>
</ref>
<ref id="bibr41-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotruck</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Ganther</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Hafeman</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Hoekstra</surname>
<given-names>WG</given-names>
</name>
</person-group> (<year>1973</year>) <article-title>Selenium: biochemical role as a component of glutathione peroxidase</article-title>. <source>Science</source> <volume>179</volume>(<issue>73</issue>): <fpage>588</fpage>–<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr42-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rzeuski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chlubek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Machoy</surname>
<given-names>Z</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Interactions between fluoride and biological free radical reactions</article-title>. <source>Fluoride</source> <volume>31</volume>: <fpage>43</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr43-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salnikow</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhitkovich</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium</article-title>. <source>Chemical Research in Toxicology</source> <volume>21</volume>: <fpage>28</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr44-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samanta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chainy</surname>
<given-names>GB</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Changes in rat testicular antioxidant defence profile as a function of age and its impairment by hexachlorocyclohexane during critical stages of maturation</article-title>. <source>Andrologia</source> <volume>31</volume>: <fpage>83</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr45-0748233711422728">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Samuel</surname>
<given-names>JB</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Reproductive toxicity of chromium on ovarian development in female Wistar rats</article-title>. <source>Ph.D. thesis</source>, <publisher-name>MS University</publisher-name>, <publisher-loc>Tirunelveli, TN, India</publisher-loc>.</citation>
</ref>
<ref id="bibr46-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuel</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Princess</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Shanthi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sebastian</surname>
<given-names>MS</given-names>
</name>
</person-group> (<year>2011a</year>) <article-title>Gestational cadmium exposure-induced ovotoxicity delays puberty through oxidative stress and impaired steroid hormone levels</article-title>. <source>Journal of Medical Toxicology</source> <volume>7</volume>(<issue>3</issue>): <fpage>195</fpage>–<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr47-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuel</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Roopha</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Vengatesh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Anbalagan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Banu</surname>
<given-names>SK</given-names>
</name>
<etal/>
</person-group>. (<year>2011b</year>) <article-title>Lactational hexavalent chromium exposure-induced oxidative stress in rat uterus is associated with delayed puberty and impaired gonadotropin levels</article-title>. <source>Human &amp; Experimental Toxicology</source> <volume>30</volume>: <fpage>91</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr48-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawicka</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Srednicka</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dlugosz</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Baicalin inhibits free radicals processes initiated by chromium ions</article-title>. <source>Acta Poloniae Pharmaceutica</source> <volume>67</volume>: <fpage>706</fpage>–<lpage>709</lpage>.</citation>
</ref>
<ref id="bibr49-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shmitova</surname>
<given-names>LA</given-names>
</name>
</person-group> (<year>1980</year>) <article-title>Content of hexavalent chromium in the biological substrates of pregnant women and puerperae engaged in the manufacture of chromium compounds</article-title>. <source>Gigiena Truda i Professional’nye Zabolevania</source> (<issue>2</issue>): <fpage>33</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr50-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>AK</given-names>
</name>
</person-group> (<year>1972</year>) <article-title>Colorimetric assay of catalase</article-title>. <source>Analytical Biochemistry</source> <volume>47</volume>: <fpage>389</fpage>–<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr51-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staal</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Visser</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Veeger</surname>
<given-names>C</given-names>
</name>
</person-group> (<year>1969</year>) <article-title>Purification and properties of glutathione reductase of human erythrocytes</article-title>. <source>Biochimica Biophysica Acta</source> <volume>185</volume>: <fpage>39</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr52-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rajendiran</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sekhar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gowri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Govindarajulu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aruldhas</surname>
<given-names>MM</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Reproductive toxicity of chromium in adult bonnet monkeys (Macaca radiata Geoffrey). Reversible oxidative stress in the semen</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>215</volume>: <fpage>237</fpage>–<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr53-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugiyama</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Role of physiological antioxidants in chromium(VI)-induced cellular injury</article-title>. <source>Free Radical Biology &amp; Medicine</source> <volume>12</volume>: <fpage>397</fpage>–<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr54-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Susa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Protective effect of vitamin E on chromium (VI)-induced cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes</article-title>. <source>Archives of Toxicology</source> <volume>71</volume>: <fpage>20</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr55-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Synergism of ascorbic acid and glutathione in the reduction of hexavalent chromium in vitro</article-title>. <source>Industrial Health</source> <volume>28</volume>: <fpage>9</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr56-0748233711422728">
<citation citation-type="book">
<collab collab-type="author">The Blacksmith Institute</collab> (<year>2007</year>) <source>The world’s worst polluted places, the top ten</source>. <publisher-loc>The Blacksmith Institute</publisher-loc>: <publisher-name>New York City</publisher-name>
<publisher-name>, USA</publisher-name>, <fpage>1</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr57-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trivedi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>SV</given-names>
</name>
</person-group> (<year>1989</year>) <article-title>Embryotoxicity and fetotoxicity of orally administered hexavalent chromium in mice</article-title>. <source>Reproductive Toxicology</source> <volume>3</volume>: <fpage>275</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr58-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>MT</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Metals, toxicity and oxidative stress</article-title>. <source>Current Medicinal Chemistry</source> <volume>12</volume>: <fpage>1161</fpage>–<lpage>1208</lpage>.</citation>
</ref>
<ref id="bibr59-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>DJ</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Occupational hazards and pregnancy outcomes</article-title>. <source>American Journal of Industrial Medicine</source> <volume>21</volume>: <fpage>397</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr60-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vallyathan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Castranova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Cr (VI) induces cell growth arrest through hydrogen peroxide-mediated reactions</article-title>. <source>Molecular and Cellular Biochemistry</source> <volume>222</volume>: <fpage>77</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr61-0748233711422728">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhitkovich</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI)</article-title>. <source>Chemical Research in Toxicology</source> <volume>18</volume>: <fpage>3</fpage>–<lpage>11</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>